Trial intelligence / Profile preview

Tradipitant gastric function study

NCT04849559Phase 2Completed

Sponsor
Vanda Pharmaceuticals Inc.
Start
Feb 2021
Primary completion
Sep 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tradipitant in gastroparesis, sponsored by Vanda Pharmaceuticals Inc.. Started Feb 2021; status: completed.

02

Drugs

tradipitant
03

Conditions

gastroparesis

Beyond the preview

Go deeper on NCT04849559.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04849559.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call